青春期
发表于 2025-3-25 03:49:50
Herwart Opitz,Hans Obrig,Karlheinz Ganseroid plaques and neurofibrillary tangles in the brain.There is a growing body of evidence to support a central role for biometals such as copper (Cu),zinc (Zn) and iron (Fe) in many critical aspects of AD and other neurodegenerative diseases. The amyloidbeta (Aβ) peptide and its parental molecule, th
BRIBE
发表于 2025-3-25 09:48:33
Herwart Opitz,Hans Obrig,Karlheinz Ganseriabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.
抚慰
发表于 2025-3-25 14:12:39
,GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease,iabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.
scotoma
发表于 2025-3-25 19:41:35
http://reply.papertrans.cn/16/1543/154256/154256_24.png
PACK
发表于 2025-3-25 21:15:25
978-3-642-09354-8Springer-Verlag Berlin Heidelberg 2008
ALTER
发表于 2025-3-26 03:59:44
http://reply.papertrans.cn/16/1543/154256/154256_26.png
雪白
发表于 2025-3-26 04:40:32
Herwart Opitz,Hans Obrig,Karlheinz Ganseriabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.
incision
发表于 2025-3-26 09:21:32
http://reply.papertrans.cn/16/1543/154256/154256_28.png
Preamble
发表于 2025-3-26 14:25:54
http://reply.papertrans.cn/16/1543/154256/154256_29.png
用树皮
发表于 2025-3-26 19:59:17
,Beyond Cholesterol: Statin Benefits in Alzheimer’s Disease,a. While early studies raised significant hopes, morerecent epidemiological studies suggest a more complex association between cholesterol, statin use andAD. Despite the controversy, prospective randomized placebo control studies in AD do support cognitive benefitfrom statin treatment. The managemen